MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Idiopathic Pulmonary Fibrosis

  1. Home
  2. Diseases
  3. Idiopathic Pulmonary Fibrosis
  4. Clinical Trials

Clinical Trials Related to Idiopathic Pulmonary Fibrosis

Related studies linked through entity extraction aliases.

NCT00105183

EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection

Status
COMPLETED
Phase
PHASE3

NCT00080223

Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis

Status
COMPLETED
Phase
PHASE2

NCT00076635

An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF

Status
TERMINATED
Phase
PHASE3

NCT00075998

The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)

Status
TERMINATED
Phase
PHASE3

NCT00074698

Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis

Status
COMPLETED
Phase
PHASE1

NCT00071461

Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis

Status
COMPLETED
Phase
PHASE2/PHASE3

NCT00047658

A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Status
COMPLETED
Phase
PHASE2

NCT00047645

A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Status
COMPLETED
Phase
PHASE3
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.